VA Providence Healthcare System (Site 074-025), 830 Chalkstone Ave. — Providence, Rhode Island

VA Providence Healthcare System (Site 074-025), 830 Chalkstone Ave. is a clinical research site located in Providence, Rhode Island, United States 02908.

Crixeo Clinical Trials Trust Score: 84/100 (GOOD). This profile has not yet been claimed by the site owner.

VA Providence Healthcare System (Site 074-025), 830 Chalkstone Ave. has participated in 2 clinical trials.

Therapeutic areas: Covid19, COVID-19.

Sponsors: National Institute of Allergy and Infectious Diseases (NIAID).

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Providence

Browse all research sites in Rhode Island · View every site in Providence

Sponsor Feasibility Report

Trust Score: 84/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for VA Providence Healthcare System (Site 074-025), 830 Chalkstone Ave.?

VA Providence Healthcare System (Site 074-025), 830 Chalkstone Ave. has a Crixeo Trust Score of 84/100 (GOOD). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has VA Providence Healthcare System (Site 074-025), 830 Chalkstone Ave. conducted?

VA Providence Healthcare System (Site 074-025), 830 Chalkstone Ave. has 2 clinical trials on record. Their work covers Covid19, COVID-19.

Is VA Providence Healthcare System (Site 074-025), 830 Chalkstone Ave. accredited by Crixeo Clinical Trials?

VA Providence Healthcare System (Site 074-025), 830 Chalkstone Ave. has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about VA Providence Healthcare System (Site 074-025), 830 Chalkstone Ave.?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.